Robert Amato is the Chief of the Oncology Division and a Professor at the University of Texas Medical School at Houston and Director of Oncology at the Memorial Hermann Cancer Center. He obtained his Doctor of Osteopathic Medicine from the University of North Texas before becoming a fellow in Medical Oncology at MD Anderson Cancer Center. Dr. Amato is one of the world’s leading experts in the treatment of genitourinary cancer. Early in his career, his research helped make testicular cancer a highly treatable disease. His current research focuses on molecular-targeted therapeutics, halting the progression of metastatic kidney and prostate cancers, the further development of immunotherapies, and determining how his studies may be used to treat genitourinary cancer.